National trends in the use of oral chemotherapy over 13 years
Background: Systemic cancer therapy has traditionally been administered using an intravenous (IV) route, implying patients’ frequent visits to hospitals to access to their therapy. If we consider the actual pipeline in oncology, oral chemotherapy will be the main component of cancer treatment in the...
Main Authors: | A. Moreira, C. Bernardo, C. Ramos, P. Aguiar, F. Alves da Costa |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.909948/full |
Similar Items
-
Exercise during chemotherapy: Friend or foe?
by: Melanie Potiaumpai, et al.
Published: (2023-05-01) -
The Impact of Pre-Chemotherapy Body Composition and Immunonutritional Markers on Chemotherapy Adherence in Stage III Colorectal Cancer Patients
by: Soohyeon Lee, et al.
Published: (2023-02-01) -
Evaluation of a Pharmacist Led Oral Chemotherapy Clinic: A Pilot Program in the Gastrointestinal Oncology Clinic at an Academic Medical Center
by: Julianne O. Darling, et al.
Published: (2020-03-01) -
Consumption of antibacterials in three hospitals in Santiago de Cuba in the period 2019-2020
by: Maraelys Morales-González, et al.
Published: (2022-11-01) -
Trends and characteristics of pethidine use in Taiwan: a six-year-long survey
by: Hsueh-Hsing Pan, et al.
Published: (2012-07-01)